TLDR The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.
The document from 2018 discussed the development of an unbiased, large-scale screening method to identify antigen epitopes in autoimmune diseases, specifically focusing on alopecia areata (AA). It highlighted the limitations of traditional methods for identifying autoantigens and proposed the use of the Immune Epitope Database and Analysis Resource (IEDB) for high-throughput epitope prediction from hair follicle proteins. The goal was to validate these predictions using peripheral blood mononuclear cells from AA patients to identify true, disease-associated autoantigen epitopes. However, the document acknowledged that this method might not capture all disease-associated epitopes and could be biased toward certain cytokines and T-cell subsets. Despite these limitations, the document emphasized the potential of this approach to improve the identification and validation of autoantigen epitopes in AA.
70 citations
,
April 2016 in “Experimental Dermatology” A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.
12 citations
,
August 2013 in “Journal of Dermatological Science” The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.
18 citations
,
July 2013 in “Journal of Leukocyte Biology” Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.
61 citations
,
September 2010 in “Genomics” The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.
66 citations
,
July 2010 in “Journal of Proteome Research” Trichohyalin may trigger the immune response causing alopecia areata.
717 citations
,
June 2010 in “Nature” Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.
286 citations
,
August 2007 in “Journal of Clinical Investigation” Alopecia areata is an autoimmune disease where T cells attack hair follicles.
April 2019 in “International journal of research in dermatology” A child with rough nails also had hair loss and allergies.
37 citations
,
October 2017 in “Clinical and Experimental Dermatology” Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.
18 citations
,
January 2010 in “Dermatology Research and Practice” DPCP treatment for alopecia areata can sometimes cause vitiligo.